12.82
price up icon1.42%   0.18
after-market Handel nachbörslich: 12.90 0.08 +0.62%
loading

Finanzdaten der Novavax Inc-Aktie (NVAX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
59.36%
56.70
139.51 147.14 70.44 239.24
Cost Of Revenue
53.59%
14.25
30.70 22.10 21.50 15.32
Selling, General, and Administrative
7.34%
26.66
28.78 - - -
Costs And Expenses
27.97%
111.60
154.94 132.91 248.46 138.17
Depreciation and Amortization
0.20%
3.056
3.062 5.125 6.585 7.563
Operating Income/Loss
255.84%
-54.91
-15.43 14.23 -178.02 101.07
Income/Loss From Continuing Operations Before Tax
507.52%
-51.68
-8.506 17.90 -203.04 107.45
Income Tax Expense/Benefit
73.71%
1.711
0.985 0.376 -0.657 0.946
Net Income/Loss
462.50%
-53.39
-9.491 17.53 -202.38 106.51
Basic Average Shares
0.79%
164.57
163.28 0.18 162.35 162.02
Diluted Average Shares
0.79%
164.57
163.28 4.908 162.35 177.22
Basic Earnings Per Share
433.33%
-0.32
-0.06 0.11 -1.25 0.66
Diluted Earnings Per Share
433.33%
-0.32
-0.06 0.05 -1.25 0.62
$41.02
price up icon 1.91%
$29.64
price down icon 1.27%
$22.75
price up icon 6.58%
$28.57
price up icon 6.84%
$56.65
price up icon 1.63%
$17.40
price up icon 1.16%
Kapitalisierung:     |  Volumen (24h):